DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, Sonke GS, Paluch-Shimon S. et al.
Ribociclib as first-line therapy for HR-positive, advanced breast cancer.
N Engl J Med 2016;
375: 1738-48
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.